XML 42 R25.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Dec. 31, 2024
Oct. 18, 2024
Nov. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Oct. 31, 2024
Sep. 30, 2024
Shares issued       7,552,500      
Common stock shares issued 74,084,041     74,084,041     63,787,104
Public offering price $ 0.31   $ 2.00 $ 0.31      
Proceeds from issuance of common stock $ 4,400,000   $ 4,500,000 $ 5,000,300 $ 4,980,000    
Net of issuance costs 600,000   $ 500,000        
Consulting Agreements [Member]              
Exercise price       $ 0.70      
Common stock issued for service, shares       500,000 88,573    
Ergomed [Member]              
Cost of shares issued   $ 61,000          
Common stock shares issued           1,000,000  
Consulting Agreements Other [Member]              
Consulting fees inclued prepaid expenses $ 51,000     $ 51,000     $ 52,000
Common stock issued for service, shares       397,000 218,000    
Restricted Stock [Member] | Consultants [Member]              
Weighted average grant date fair value       $ 0.85 $ 1.56    
Common stock issued for service, shares       154,615 88,573    
Pre-Funded [Member]              
Common stock shares issued 8,577,500     8,577,500      
Common stock shares issued 8,577,500     8,577,500      
Public offering price $ 0.3099     $ 0.3099      
Changes in Equity Warrants [Member]              
Common stock shares issued 8,577,500     8,577,500 1,450,000    
Public offering price $ 0.3099     $ 0.3099